BiomX Announced Safety And Efficacy Results From Part 2 Of The Phase 1B/2A Trial Of BX004 For Chronic Pulmonary Infections Due To Pseudomonas Aeruginosa In Cystic Fibrosis Patients, Showing Clinically Meaningful Improvement In Pulmonary Function
Benzinga Newsdesk - Nov 29, 2023, 6:33AM